Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions

Canadian Journal of Cardiology

Volumn 12, Issue 4, 1996, Pages 353-362

  Tyagi, Suresh C ^a   Meyer, Larry ^b   Kumar, Suresh ^b   Schmaltz, Richard A ^b   Reddy, Hanumanth K ^b   Voelker, Donald J ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b NONE

Author keywords

Atherosclerosis; Extracellular matrix; Matrix metalloproteinase; Restenosis; Tissue inhibitor of metalloproteinase; Tissue plasminogen activator

Indexed keywords

COLLAGEN; COLLAGENASE; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOPLASTY; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; MITOGENESIS; RESTENOSIS;

ANIMALS; ARTERIOSCLEROSIS; ATHERECTOMY; CORONARY DISEASE; DISEASE MODELS, ANIMAL; ENDOTHELIUM; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMANS; METALLOENDOPEPTIDASES; MITOGENS; RATS; RECURRENCE; TISSUE PLASMINOGEN ACTIVATOR; UNITED STATES;

EID: 0029985227     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ross R. The pathogenesis of atherosclerosis. Nature 1993;362:801-3.
2. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-71.
3. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ. Proteinases and restenosis in human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 1995;116:43-57.
4. Tyagi SC, Matsubara L, Weber KT. Direct extraction and estimation of collagenase(s) activity by zymography in microquantitites of rat myocardium and uterus. Clin Biochem 1993;26:191-8.
5. Tyagi SC, Ratajaska A, Weber KT. Myocardial matrix metalloproteinases: localization and activation. Mol Cell Biochem 1993;126:49-59.
6. Ip JH, Fuster V, Isreal D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin, and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17:77B-88B.
7. Chua CC, Chua BHL, Zhao ZY, Krebs C, Diglio C, Perrin E. Effect of growth factor on collagen metabolism in cultured human heart fibroblasts. Connect Tissue Res 1991;26:271-81.
8. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991;68:106-13.
9. Yanagi H, Sasagun Y, Sugama K, Morimatsu M, Nagase H. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis 1991;91:207-16.
10. Galis ZS, Muszynski M, Sukhova GK, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzyme required for extracellular matrix digestion. Circ Res 1994;75:181-9.
11. Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758-69.
12. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781-4.
13. Nemeth JA, Goolsby CL. TIMP-2, a growth-stimulatory protein from SV40 transformed human fibroblasts. Exp Cell Res 1993;207:376-82.
14. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of TIMP-1 for a wide range of cells. FEBS Lett 1992;298:29-32.
15. Tyagi SC, Kumar SG, Glover G. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells. J Cell Biochem 1995;58;360-71.
16. Peuhkurinen KJ, Risteli L, Melkko JT, Linnaluoto M, Jounela A, Risteli J. Thrombolytic therapy with streptokinase stimulates collagen breakdown. Circulanon 1991;83:1969-75.
17. Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic processing of the 72 kDa type IV collagenase by urokinase plasminogen activator. J Exp Cell Res 1992;202:471-6.
18. Tyagi SC, Simon SR. Role of disulfide exchange in alpha-1 protease inhibitor. Biochemistry 1992;31:10584-90.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
20. 4. Nature 1970;227:650-5.
21. Bumette WN. "Western botting": electrophoretic transfer of proteins from SDS-PAGE to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981;112:195-203.
22. Tyagi SC, Kumar SG, Banks J, Fortson W. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J Mol Cell Cardiol 1995;27:2177-89.
23. Guarda E, Myers PR, Brilla CG, Tyagi SC, Weber KT. Endothelial cell-induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc Res 1993;27:1004-8.
24. Ward RV, Hembry RM, Reynolds JJ, Murphy G. The purification of tissue inhibitor of metalloproteinase-2 (TIMP-2) from its 72 kDa progelatinase complex; demonstration of the biochemical similarities of TIMP-2 and TIMP-1. Biochem J 1991;278:179-87.
25. Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 1990;29:10261-70.
26. Haugland RP. Molecular Probes: A Handbook of Fluorescent Probes and Research Chemicals. Eugene: Larison KD, 1994:22-4.
27. Connolly DT, Knoght MB, Harakas NK, Wittwer AJ, Feder J. Determination of number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem 1986;152:136-40.
28. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994;75:539-45.
29. Dixit SN, Mainardi CL, Seyer JM, Kang AH. Covalent structure of collagen: amino acid sequence of alpha 2-CB5 of chick skin collagen containing the animal collagenase cleavage site. Biochemistry 1979;18:5416-22.
30. Goldberg GI, Manner BL, Grant GA, Eisen AZ, Wilhelm S, He CS. Human 72-kDa type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designed TIMP-2. Proc Nad Acad Sci USA 1989;86:8207-11.
31. Gavrilovic J, Hembry RM, Reynolds JJ, Myrphy G. Tissue inhibitor of metalloproteinases (TIMP) regulates ectracellular type I collagen degradation by chondrocytes and endothelial cells. J Cell Sci 1987;87:357-62.
32. Moses MA, Langer R, A metalloproteinase inhibitor as an inhibitor of neovascularization. J Cell Biochem 1991;47:230-5.
33. Murphy G, Docherty AJP. Molecular studies on the connective tissue metalloproteinases and their inhibitor TIMP. In: Glauert AM, ed. The Control of Tissue Damage. Amsterdam: Elsevier Science Publishers, 1991:223-41.
34. Vater CA, Nagase H, Harris ED Jr. Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. J Biol Chem 1983;258:9374-82.
35. Ishihashi M, Ito A, Sakyo K, Mori Y. Procollagenase activator produced by rabbit uterine cervical fibroblasts. Biochem J 1987;241:527-34.
36. Treadwell BV, Neidel J, Pavia M, Towle CA, Trice ME, Mankin HJ. Purification and characterization of collagenase activator protein synthesized by articular cartilage. Arch Biochem Biophys 1986;251:715-23.
37. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJP. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 1987;248:265-8.
38. Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 1988;267:211-6.
39. Werb Z, Mainardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 1977;296:1017-23.
40. Vaes G. Multiple steps in the activation of the inactive precursor of bone collagenase by trypsin. FEBS Lett 1972;28:198-200.
41. Mathey DG, Kuck KH, Tilsner V, Krebber HJ, Bleifeld W. Non surgical coronary artery recanalization in acute transmural myocardial infarction. Circulation 1981;63:489-97.
42. Kennedy JW, Gensini GG, Timmis GC, Maynard C. Acute myocardial infarction treated with intracoronary streptokinase: a report of the Society for Cardiac Angiography. Am J Cardiol 1985;55:871-7.